Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Plasmacytoma × daratumumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 93 Neoplasms, Plasma Cell 10 Immunoglobulin Light-chain Amyloidosis 9 Recurrence 7 Neoplasm, Residual 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 3 Waldenstrom Macroglobulinemia 2 Smoldering Multiple Myeloma 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Paraproteinemias 2 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Acute Kidney Injury 2 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Renal Insufficiency 1 Proteostasis Deficiencies 1 Primary Myelofibrosis 1 Plasmacytoma 1 Non-small Cell Lung Cancer With STK11/LKB1 Mutation 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Radiotherapy 2 Lenalidomide 2 Dexamethasone 2 pomalidomide 1 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 cc-486 1 auricularum 1 Thalidomide 1 Sodium Selenite 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Immunotherapy, Adoptive 1 Gemcitabine 1 Drug Combinations 1 Calcium Dobesilate 1 Busulfan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065308 2019-08-22

Dara_DCEP

Seoul National University Hospital

Phase 2 Unknown

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡